Publication | Closed Access

Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo

MedicinePotent Antitumor ActivityHer2-specific DarpinSelective ToxicityTumor TargetingAnti-cancer AgentPharmacologyCell BiologyCancer ResearchTumor BiologyDrug Discovery